General practitioners and medical oncologists in the management of patients with cancer: An Italian national programme initiated with the CIPOMO DAY 2022
Cinzia Ortega(Candiolo Cancer Institute), Luigi Cavanna(University of Pavia), Rosa Rita Silva, Monica Giordano(Ospedale Sant'Anna), Maria Giuseppina Sarobba, Stefania Crivellari(Ospedale San Pietro Fatebenefratelli), A. Scanni, Paolo Tralongo(Unknown), Sandro Barni, Bruno Daniele(Azienda Ospedaliera G.Rummo), Livio Blasi, Luisa Fioretto(Ospedale SS. Annunziata), C. Aschele(Ospedale San Carlo), Giuseppe Aprile(Ospedale Santa Maria della Misericordia di Udine), Graziella Pinotti(Medica (Italy)), Vincenzo Montesarchio(CTO Hospital), Silvana Leo(Ospedale Vito Fazzi), Fabrizio Artioli(Roche (Switzerland))
Cited by 0
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k